ATE507309T1 - Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung - Google Patents

Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Info

Publication number
ATE507309T1
ATE507309T1 AT09151217T AT09151217T ATE507309T1 AT E507309 T1 ATE507309 T1 AT E507309T1 AT 09151217 T AT09151217 T AT 09151217T AT 09151217 T AT09151217 T AT 09151217T AT E507309 T1 ATE507309 T1 AT E507309T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
oral squamous
suppressing
carcinoma
detecting
Prior art date
Application number
AT09151217T
Other languages
English (en)
Inventor
Johji Inazawa
Ken-Ichi Kozaki
Issei Imoto
Original Assignee
Fujifilm Corp
Nat Univ Corp Tokyo Med & Dent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp, Nat Univ Corp Tokyo Med & Dent filed Critical Fujifilm Corp
Application granted granted Critical
Publication of ATE507309T1 publication Critical patent/ATE507309T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT09151217T 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung ATE507309T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008012256A JP5116026B2 (ja) 2008-01-23 2008-01-23 癌の検出方法および癌抑制剤

Publications (1)

Publication Number Publication Date
ATE507309T1 true ATE507309T1 (de) 2011-05-15

Family

ID=40748687

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09151217T ATE507309T1 (de) 2008-01-23 2009-01-23 Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung

Country Status (5)

Country Link
US (2) US20090202624A1 (de)
EP (1) EP2088208B1 (de)
JP (1) JP5116026B2 (de)
AT (1) ATE507309T1 (de)
DE (1) DE602009001116D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119698A1 (ja) * 2009-04-16 2010-10-21 学校法人 慶應義塾 頭頸部腫瘍増殖抑制剤
EP2283846A1 (de) * 2009-08-12 2011-02-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. miRNA-Verbindungen zur Behandlung von Prostatakarzinomen
WO2011040613A1 (ja) * 2009-10-01 2011-04-07 独立行政法人国立がん研究センター 腫瘍治療剤
WO2011067346A1 (en) * 2009-12-04 2011-06-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for determining the efficiency of a cancer treatment
JP5775517B2 (ja) 2010-07-08 2015-09-09 武田薬品工業株式会社 糖尿病の予防・治療剤
KR101532210B1 (ko) * 2011-05-06 2015-06-29 중산 호스피탈 푸단 유니버시티 플라즈마 마크로알엔에이로 구성된 간암 진단 마커 및 간암 진단의 새로운 방법
WO2013038737A1 (ja) 2011-09-16 2013-03-21 北海道公立大学法人 札幌医科大学 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ
WO2013071502A1 (en) * 2011-11-17 2013-05-23 Genedia Biotech Co Ltd Mir-193a-3p and associated genes predict tumorigenesis and chemotherapy outcomes
EP3369818B1 (de) * 2011-12-22 2021-06-09 InteRNA Technologies B.V. Mirna zur behandlung von kopf-hals-karzinom
JP6587142B2 (ja) 2013-02-15 2019-10-09 国立大学法人 東京医科歯科大学 マイクロrnaからなるがん治療剤
WO2017079571A1 (en) * 2015-11-05 2017-05-11 Arphion Diagnostics Process for the indentication of patients at risk for oscc
WO2019093308A1 (ja) * 2017-11-09 2019-05-16 国立大学法人広島大学 miRNAを含むがん治療用医薬組成物
WO2019117270A1 (ja) * 2017-12-13 2019-06-20 国立大学法人広島大学 頭頸部がんの検出を補助する方法
EP3976058A4 (de) * 2019-06-03 2023-07-19 Carmel-Haifa University Economic Corporation Ltd. Behandlung von kopf-hals-karzinom beim menschen
KR20220042117A (ko) 2019-08-09 2022-04-04 우베 고산 가부시키가이샤 엑소좀의 생성 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554818A1 (en) 2004-02-09 2005-08-25 Thomas Jefferson University Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
EP2302055B1 (de) 2004-11-12 2014-08-27 Asuragen, Inc. Verfahren und Zusammensetzungen, die miRNAs und miRNAa-inhibitorischen Molekülen verbunden sind
EP1969147B1 (de) * 2006-01-05 2014-07-30 The Ohio State University Research Foundation mikro-RNA-basierte verfahren zur Diagnose von Magenkrebs
ES2553442T3 (es) * 2006-01-05 2015-12-09 The Ohio State University Research Foundation Procedimientos basados en los microARN para el diagnóstico, pronóstico y tratamiento del cáncer de pulmón
WO2007126150A1 (ja) * 2006-04-27 2007-11-08 National University Corporation Nagoya University 癌の新規治療用組成物
EP2041317A4 (de) * 2006-07-13 2009-10-14 Univ Ohio State Res Found Mikro-rna-basierte verfahren und zusammensetzungen zur diagnose und behandlung von erkrankungen in zusammenhang mit darmkrebs

Also Published As

Publication number Publication date
DE602009001116D1 (de) 2011-06-09
JP2009171876A (ja) 2009-08-06
US20090202624A1 (en) 2009-08-13
US8183223B2 (en) 2012-05-22
US20110076768A1 (en) 2011-03-31
EP2088208A1 (de) 2009-08-12
JP5116026B2 (ja) 2013-01-09
EP2088208B1 (de) 2011-04-27

Similar Documents

Publication Publication Date Title
ATE507309T1 (de) Verfahren zur erkennung eines oralen plattenepithelkarzinoms und mittel zu dessen unterdrückung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
DE602007002090D1 (de) Verfahren zur Erkennung von anaplastischem Schilddrüsenkrebs, und Verfahren zur seiner Unterdrückung
EP4461824A3 (de) Kit oder vorrichtung zur erkennung von gallengangkrebs und nachweisverfahren
EP3971299A3 (de) Kolorektalkrebsdetektionskit oder -vorrichtung und detektionsverfahren
DK3581662T3 (da) Sammensætninger og fremgangsmåder til detektering og identificering af nukleinsyresekvenser i biologiske prøver
HK1211260A1 (en) Method and kit for nucleic acid sequencing
WO2015058008A3 (en) Enhanced nucleic acid identification and detection
EP2547809A4 (de) Verfahren, sondensets und kits zur erkennung der zerstörung von tumorunterdrückergenen durch in-situ-fluoreszenz-hybridisierung
WO2008054556A3 (en) Methods and compositions for detection of a target nucleic acid sequence
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
AT10182U3 (de) Verfahren zur überwachung von leistungsprüfständen, sowie leistungsprüfstand
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
MX363880B (es) Sondas, cebadores cooperativos y aplicaciones de ellos.
DE602006003880D1 (de) Verfahren zur herstellung von multimetallkatalysatoren, die bei kohlenwasserstoffumwandlungsreaktionen verwendet werden können
ATE544070T1 (de) Verfahren zum nachweis von tumorspezifischen fusionsproteinen
ATE418213T1 (de) Verfahren und vorrichtung zur überprüfung der integrität eines wartungszusammenhangs sowie verfahren und vorrichtung zum einfügen eines wartungsendpunktes
WO2013062261A3 (en) Newly identified colon cancer marker and diagnostic kit using the same
MX359369B (es) Método para el diagnóstico y/o pronóstico de daño renal agudo.
HK1205278A1 (en) Method for removing a high definition nanostructure, a partly freestanding layer, a sensor comprising said layer and a method using said sensor
ATE544474T1 (de) Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird
WO2012135620A3 (en) Molecular gram stain
GB201317680D0 (en) Representation of spatial-frequency data as a map

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties